Table 3.
Unadjusted association of sociodemographic and clinical parameters with healthy liver, steatosis, and liver fibrosis, Cameron County Hispanic Cohort
| Steatosis vs Healthya | Fibrosis vs Healthy | Fibrosis vs Steatosis | ||||
|---|---|---|---|---|---|---|
|
| ||||||
| Variable | OR (95% CI)b | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value |
| Age (years) | 1.0 (0.8 - 1.3) | 0.7975 | 0.8 (0.6 - 1.0) | 0.0671 | 0.8 (0.6 - 1.0) | 0.0475 |
| Male Sex | 0.9 (0.5 - 1.7) | 0.7313 | 1.7 (0.8 - 3.7) | 0.1473 | 1.9 (0.8 - 4.6) | 0.1259 |
| Diabetesc | 1.9 (1 - 3.8) | 0.0654 | 1.3 (0.5 - 3.2) | 0.6361 | 0.7 (0.3 - 1.6) | 0.3371 |
| Fasting Glucose (per 10 mg/dL) | 1.1 (1.0 - 1.2) | 0.0156 | 1.1 (0.9 - 1.2) | 0.4311 | 1.0 (0.8 - 1.1) | 0.4818 |
| Hemoglobin A1c (%) | 1.2 (0.9 - 1.5) | 0.3242 | 1.1 (0.9 - 1.5) | 0.4220 | 1.0 (0.8 - 1.2) | 0.7178 |
| Insulin (10 mg/dL) | 2.8 (1.6 - 4.7) | 0.0002* | 1.4 (0.7 - 2.6) | 0.3294 | 0.5 (0.2 - 1.1) | 0.0832 |
| HOMA-IR | 1.4 (1.2 - 1.7) | <0.0001* | 1.1 (0.9 - 1.4) | 0.3072 | 0.8 (0.6 - 1.1) | 0.1047 |
| Diastolic BP (mmHg)d | 1.4 (1.0 - 2.0) | 0.0375 | 1.1 (0.6 - 2.0) | 0.7770 | 0.8 (0.4 - 1.5) | 0.4540 |
| Hypertensione | 1.1 (0.5 - 2.4) | 0.7585 | 1.0 (0.4 - 2.6) | 0.9979 | 0.9 (0.3 - 2.5) | 0.8260 |
| Triglycerides (per 50 mg/dL) | 1.4 (1.1 - 1.8) | 0.0033* | 1.1 (0.6 - 1.9) | 0.7381 | 0.8 (0.4 - 1.4) | 0.3992 |
| HDL Cholesterol (mg/dL) | 0.6 (0.4 - 0.8) | 0.0003* | 0.9 (0.6 - 1.3) | 0.5098 | 1.5 (1.0 - 2.3) | 0.0421 |
| AST (per 10 units/L) | 1.4 (1.1 - 1.9) | 0.0176 | 1.5 (1.1 - 2.0) | 0.0080 | 1.1 (1.0 - 1.1) | 0.2640 |
| ALT (per 10 units/L) | 1.5 (1.2 - 1.8) | 0.0005* | 1.4 (1.2 - 1.8) | 0.0014* | 1.0 (0.9 - 1.1) | 0.5715 |
| AST/ALT Ratio | 0.5 (0.1 - 3.5) | 0.4546 | 1.9 (0.7 - 5.6) | 0.2227 | 4.2 (0.5 - 38.4) | 0.2016 |
| Obesef | 3.0 (1.7 - 5.5) | 0.0001* | 1.5 (0.7 - 3.4) | 0.2828 | 0.5 (0.2 - 1.2) | 0.1039 |
| Waist Circumference (per 10 cm) | 1.0 (1.0 - 1.0) | 0.0002* | 1.0 (1.0 - 1.0) | 0.7556 | 0.7 (0.5 - 1.0) | 0.0408 |
| Platelets (per 50×103/μL) | 1.1 (0.8 - 1.4) | 0.5600 | 0.8 (0.6 - 1.1) | 0.1680 | 0.7 (0.4 - 1.0) | 0.0649 |
| Anti-HCV | 8.4 (0.9 - 79.4) | 0.0646 | 18.9 (1.8 - 196.4) | 0.0138 | 2.3 (0.4 - 11.7) | 0.3285 |
| Drinks per week | 1.0 (0.9 - 1.1) | 0.7294 | 1.1 (1.0 - 1.2) | 0.0358 | 1.1 (1.0 - 1.1) | 0.0505 |
| Heavy Drinkingg | 0.7 (0.1 - 7.6) | 0.7913 | 5.5 (0.6 - 52.3) | 0.1368 | 7.6 (1.0 - 56.8) | 0.0493 |
Abbreviations: OR, Odds Ratio; CI, confidence interval; HOMA-IR, homeostasis model of insulin resistance ; BP, blood pressure; LDL, low-density lipoprotein; HDL, high-density lipoprotein; AST, aspartate aminotransferase; ALT, alanine aminotransferase; NAFLD, non-alcoholic fatty liver disease;
Note. Statistical tests significant at the 5% level after correction for false discovery rate are indicated with an asterisk.
Healthy indicates no evidence of steatosis and liver stiffness ≤ 1.34; steatosis indicates evidence of steatosis and liver stiffness ≤ 1.34 m/s; fibrosis indicates liver stiffness > 1.34 m/s
OR, 95% CI and P-value obtained from survey-based multinomial logistic regression
According to American Diabetes 2010 Diagnostic Guidelines
Blood pressure analyses are adjusted for self-reported use of antihypertensive medication
Systolic Blood Pressure > 135 or Diastolic Blood Pressure > 85 or taking antihypertensive medication
BMI ≥ 30
For men, greater than 21 self-reported drinks per week; for women, greater than 14 drinks per week.